Morgan Stanley

MS is in a Stage 2 corrective consolidation above flat short-term EMAs and the rising 200 DMA. The medium-term bias remains bullish, anchored by the intact uptrend, but short-term conditions are neutral as price tracks the EMA bundle. We defer new entries, stalking a pullback into the EMA support zone around the 212–214 area or a decisive break above recent resistance before engaging.

• ↑Q2 2026 revenue $21.3B (+27.1% YoY) and EPS $3.46 vs est. $2.89.
• ↑Wealth management assets reached $10T; organic net new assets of $148B.
• ↓Rising interest rates risk compressing margins despite top-line growth.